Healthcare Industry News: vascular access
News Release - April 12, 2012
Revolutions Medical Signs Distribution Agreement With Sungwon MedicalCHARLESTON, S.C., April 12, 2012 -- (Healthcare Sales & Marketing Network) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP.PK ) announced today that it has entered into a marketing and distribution agreement with Sungwon Medical Co., Ltd., ("Sungwon Medical" or "Sungwon"), a medical equipment and device distribution company based in Cheongju City, South Korea, to distribute the Company's RevVac(TM) auto-retractable vacuum safety syringe. Pursuant to the terms of the agreement, Sungwon was granted exclusive distribution rights of the RevVac(TM) safety syringe in South Korea with minimum order requirements of 1.5 million units per quarter. Sungwon will work with the Company to register the product with the South Korean Food and Drug Administration prior to distributing the product in South Korea. Sungwon also placed an order with the Company mainly for initial marketing and product awareness.
"We have many good relationships with doctors and hospitals in South Korea and feel confident they will be impressed by the RevVac(TM) auto-retractable vacuum safety syringe. We are going to work aggressively with Revolutions Medical to market the RevVac(TM) safety syringe," stated David Hee Lee, Managing Director of Sungwon Medical.
Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated, "The Company is excited to be working with Sungwon Medical to introduce the RevVac(TM) safety syringe, the next generation safety syringe, in South Korea. We are impressed by Sungwon's capabilities, relationships and command of the market."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac(TM) Safety Syringe (FDA cleared), safety blood drawing device, the RevColor(TM), RevDisplay(TM), and Rev3D(TM) software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com
To be added to the Revolutions Medical investor email list, please email: firstname.lastname@example.org with RMCP in the subject line.
About Sungwon Medical Co., Ltd.
Sungwon Medical Company, Ltd. is a medical product supply company that operates in the Cheongju City and serves the South Korean market. The firm designs and produces the safest and most innovative devices which are available for the improvement of vascular access. The company's website is http://www.swmed.kr
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Source: Revolutions Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.